“We are excited for NAMSA to serve as an exclusive partner to help patients access joimax®’ endoscopic technologies,” Joimax General Manager Maximilian Ries said in a July 21 news release. “We’re optimistic that with NAMSA’s assistance, and the nearly 5,000 clinical papers on endoscopic spine surgery, we will continue to expand coverage of this important, minimally-invasive technology.”
Bringing new medical devices to the market can be complicated, and “global medical device organizations sometimes lack the proper context and contacts when distinguishing effective reimbursement and commercialization strategies,” according to NAMSA’s website.
Joimax develops and markets complete systems for endoscopic and minimally invasive spine surgery. As a contract research organization focused on medical devices, Irvine, Calif.-based NAMSA helps companies develop medical devices from start to finish, including testing, quality assurance and clinical research.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
